gemcitabine has been researched along with Experimental Hepatoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, D; Kendre, G; Kühnel, F; Lorz, G; Marhenke, S; Marquardt, JU; Murugesan, K; Pich, A; Poth, T; Reineke-Plaaß, T; Saborowski, A; Saborowski, M; Vogel, A; Wirtz, RM; Woller, N | 1 |
| Dou, J; Fan, H; Guo, J; Li, J; Shen, B; Wang, X; Xie, X; Zhou, C; Zhou, Y | 1 |
| Cabella, C; Canapè, C; Catanzaro, G; Colombo Serra, S; Jensen, PR; Karlsson, M; Lerche, MH; Miragoli, L; Poggi, L; Tedoldi, F; Uggeri, F; Venturi, L | 1 |
| Aiura, K; Ito, Y; Kitagawa, Y; Kitajima, M; Ueda, M | 1 |
| Deng, HX; Kan, B; Li, J; Mei, K; Tian, L; Wei, YQ; Wen, YJ | 1 |
| Deng, HX; Ding, ZY; Hou, JM; Kan, B; Li, J; Li, Q; Liu, JY; Lou, YY; Mao, YQ; Niu, T; Tan, GH; Tian, L; Wei, YQ; Wen, YJ; Wu, Y; Xiao, F; Yang, JL; Yang, L; Zhao, X | 1 |
| Aoyagi, Y; Enomoto, T; Nakajima, M; Noguchi, M; Oda, T; Ohkohchi, N; Satake, M; Sugiura, S | 1 |
| Henson, R; Meng, F; Patel, T | 1 |
| Altmann, A; Bellemann, ME; Blatter, J; Brix, G; Doll, J; Haberkorn, U; Kamencic, H; Kinscherf, R; Morr, I; Traut, U | 1 |
| Ban, J; Weber, G | 1 |
10 other study(ies) available for gemcitabine and Experimental Hepatoma
| Article | Year |
|---|---|
The Co-mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion-Driven Cholangiocarcinoma.
Topics: Adenosylhomocysteinase; Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Proliferation; Cell Transformation, Neoplastic; Cholangiocarcinoma; Co-Repressor Proteins; Cyclic AMP Response Element-Binding Protein A; Deoxycytidine; Fetal Proteins; Gemcitabine; Gene Fusion; Liver Neoplasms, Experimental; Mice; Microtubule-Associated Proteins; Mutation; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Vesicular Transport Proteins | 2021 |
Enhanced antitumor activity of gemcitabine by polysaccharide-induced NK cell activation and immune cytotoxicity reduction in vitro/vivo.
Topics: Animals; Cytotoxicity, Immunologic; Deoxycytidine; Gemcitabine; Hep G2 Cells; Histocompatibility Antigens Class I; Humans; Killer Cells, Natural; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; NK Cell Lectin-Like Receptor Subfamily K; Polysaccharides; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Reactive Oxygen Species; Receptors, Immunologic; Spleen; Strongylocentrotus | 2017 |
In vivo and in vitro liver cancer metabolism observed with hyperpolarized [5-(13)C]glutamine.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Carbon Isotopes; Cell Line, Tumor; Deoxycytidine; Gemcitabine; Glutaminase; Glutamine; Liver Neoplasms, Experimental; Magnetic Resonance Spectroscopy; Rats | 2013 |
Establishment of combined immuno-chemotherapy with systemically administered gemcitabine and intra-portal administration of interleukin-2 in murine models of liver metastases of pancreatic cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Deoxycytidine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gemcitabine; Interleukin-2; Liver Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Portal Vein; T-Lymphocytes | 2008 |
[Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine].
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Lewis Lung; Chemokine CXCL10; Chemokines, CXC; Deoxycytidine; Drug Synergism; Escherichia coli; Female; Gemcitabine; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microcirculation; Neovascularization, Pathologic; Plasmids; Transfection | 2005 |
Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Carcinoma, Lewis Lung; Deoxycytidine; Drug Administration Schedule; Drug Synergism; Female; Gemcitabine; In Situ Nick-End Labeling; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Quail; Random Allocation; Vaccines, Synthetic; Vascular Endothelial Growth Factor Receptor-2 | 2005 |
Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Disease Models, Animal; Gemcitabine; Humans; Injections, Intravenous; Irinotecan; Liver Neoplasms, Experimental; Mice; Mice, Nude; Microspheres; Neoplasm Transplantation; Pancreatic Neoplasms; Portal Vein; Rats; Rats, Nude; Transplantation, Heterologous | 2006 |
Chemotherapeutic stress selectively activates NF-kappa B-dependent AKT and VEGF expression in liver cancer-derived endothelial cells.
Topics: Animals; Antigens, CD; Antimetabolites, Antineoplastic; Apoptosis; Cadherins; Cell Movement; Cells, Cultured; Deoxycytidine; Diethylnitrosamine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelial Cells; Gemcitabine; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Microcirculation; Neovascularization, Pathologic; NF-kappa B; Phenotype; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Receptors, Cell Surface; Time Factors; Transfection; Vascular Endothelial Growth Factor A | 2007 |
Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine.
Topics: 3-O-Methylglucose; Animals; Antimetabolites, Antineoplastic; Apoptosis; Deoxycytidine; DNA, Neoplasm; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Immunohistochemistry; Liver Neoplasms, Experimental; Neoplasm Transplantation; Phosphorylation; Radiopharmaceuticals; Rats; Rats, Inbred Strains; Thymidine; Tomography, Emission-Computed; Tumor Cells, Cultured | 2001 |
Synergistic action of tiazofurin and difluorodeoxycytidine on differentiation and cytotoxicity.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Differentiation; Cell Line; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; Gemcitabine; Humans; IMP Dehydrogenase; Kinetics; Leukemia, Promyelocytic, Acute; Liver Neoplasms, Experimental; Models, Biological; Ovarian Neoplasms; Pancreatic Neoplasms; Rats; Ribavirin; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Stem Cell Assay | 1992 |